Body Fat Distribution and Your Exercise Response

By the ExomeDNA Research Team | Last reviewed 2026-05-29

This page contains general information only. For personal health decisions, consult a qualified clinician.

Body fat distribution describes where your body preferentially stores fat — in the abdomen and organs (visceral), or in the hips, thighs, and limbs (subcutaneous). This measure is clinically distinct from how much fat you carry overall: two people with identical BMI can have dramatically different fat distribution patterns, with meaningfully different metabolic consequences. Genetics influences this patterning through extracellular matrix remodeling, branched-chain amino acid metabolism, and adipose tissue architecture. Below: what the research on waist circumference adjusted for BMI reveals, which genes are involved, and what you can do with this information.

What is body fat distribution?

Body fat distribution refers to the pattern of fat storage across different body compartments. The key distinction is between visceral fat — stored around the abdominal organs — and subcutaneous fat — stored beneath the skin in the hips, thighs, and periphery. This trait is measured by waist circumference adjusted for BMI (WHRadjBMI), which specifically captures fat distribution independently of total body fat mass. Central adiposity — a higher proportion of visceral relative to subcutaneous fat — carries a stronger association with metabolic and cardiovascular risk than overall BMI alone.

Visceral fat is metabolically active in ways subcutaneous fat is not. It sits in close proximity to the portal circulation, releasing free fatty acids and inflammatory signals directly into the liver. This proximity drives insulin resistance, dyslipidemia, and chronic low-grade inflammation — pathways that link central adiposity to cardiometabolic health. The genetic architecture of body fat distribution is distinct from that of BMI or total fat mass; variants that shape WHERE fat goes operate through different biological mechanisms than variants shaping HOW MUCH fat accumulates.

The genetics behind body fat distribution

The genetic basis of body fat distribution operates substantially through extracellular matrix (ECM) remodeling in adipose tissue. Adipose tissue has an elaborate scaffold of collagen, proteoglycans, and glycoproteins determining how each fat depot expands, stiffens, and responds to metabolic signals.

ADAMTS3 encodes a metalloproteinase that processes procollagen type II, required for fibrillar collagen assembly. In adipose tissue, ECM composition and stiffness differ significantly between visceral and subcutaneous depots. ADAMTS3 remodels the collagen-proteoglycan matrix of these depots, influencing whether fat preferentially accumulates centrally or peripherally. Visceral adipose tissue typically has a stiffer, less expansible ECM architecture than subcutaneous adipose; ADAMTS3 variants that alter collagen processing may shift this balance.

ADAMTS9 is a closely related metalloprotease that cleaves versican and aggrecan — two major proteoglycans in the adipose ECM. Versican and aggrecan regulate ECM stiffness and the mechanical properties of fat depots. ADAMTS9 variants alter ECM dynamics in a depot-specific way: differences in versican turnover between visceral and subcutaneous adipose affect adipocyte differentiation and expansion capacity. Research suggests that ECM stiffness influences whether preadipocytes preferentially differentiate in central versus peripheral depots (Graff et al. 2017).

ADAMTSL3 encodes an ADAMTS-like protein that modulates the activity of ADAMTS metalloproteases and regulates fibrillin microfibril assembly. Fibrillin microfibrils form the scaffolding networks that surround adipocytes and shape depot architecture. Variants in ADAMTSL3 that alter microfibril networks could influence the structural environment of visceral versus subcutaneous fat compartments.

ACAN encodes aggrecan, the major large proteoglycan of ECM tissues. Aggrecan forms enormous aggregates with hyaluronan, creating the gel-like ECM infrastructure that determines tissue mechanical properties. Visceral adipose tissue has higher ECM rigidity in part because of its aggrecan content and organization. ACAN variants that alter aggrecan production or structure may affect the mechanical expandability of fat depots in different body compartments, shaping which depot fills first as fat mass increases.

BCKDHB introduces a distinct metabolic mechanism. It encodes the E1-beta subunit of the branched-chain keto acid dehydrogenase complex, the rate-limiting enzyme in BCAA (leucine, isoleucine, valine) catabolism. When BCKDHB activity is reduced, BCAAs accumulate in plasma. Elevated BCAAs are a robust biomarker of insulin resistance. Visceral adipose tissue has lower BCAA-catabolizing activity than subcutaneous fat, creating a self-reinforcing cycle between central adiposity and impaired BCAA metabolism.

Together, these five genes sketch a picture of body fat distribution driven by ECM scaffold architecture (ADAMTS3, ADAMTS9, ADAMTSL3, ACAN) and metabolic signaling through BCAA pathways (BCKDHB) — two largely independent biological axes converging on the same phenotype.

What the research says

Research base: Moderate. The genetic associations underlying waist circumference adjusted for BMI have been identified in genome-wide association study meta-analyses across large multi-ancestry cohorts, with replicated effects reported across independent samples. A key 2017 study by Graff and colleagues examined genome-wide physical activity interactions in adiposity traits, including WHRadjBMI, in a meta-analysis of over 200,000 participants (Graff et al. 2017). This study identified associations in or near genes including those in the ADAMTS and ACAN families, and importantly found that physical activity modified several of these fat distribution associations — suggesting that lifestyle factors interact with genetic predisposition on this trait specifically.

The WHRadjBMI measure is analytically designed to isolate fat distribution from total fat mass. By adjusting waist circumference for BMI before running association analyses, the GWAS specifically targets genetic variants that shape WHERE fat is stored rather than confounding distribution genetics with total obesity genetics. This methodological choice is scientifically meaningful: it identified a distinct set of loci from BMI GWAS hits, confirming that distribution and quantity are genetically separable phenotypes.

Evidence in non-European ancestries is less complete. The largest WHRadjBMI meta-analyses have been conducted primarily in European-ancestry cohorts, with some multi-ancestry replication. Effect sizes and locus-specific signals may differ across ancestral backgrounds. ExomeDNA scores are calibrated using ancestry-aware percentile normalization — see our methodology for the full statistical approach.

The physical activity interaction finding from Graff et al. 2017 is particularly notable for this trait. Across most GWAS, gene-environment interactions are difficult to detect reliably. The fat distribution GWAS specifically powered for physical activity interactions found that regular exercise modifies several genetic associations — meaning the same genetic predisposition toward central adiposity may express differently depending on physical activity level. This is one of the stronger gene-environment interaction signals in the adiposity genetics literature.

How body fat distribution affects you

A higher result on this trait indicates a genetic predisposition toward more central (visceral) fat distribution relative to peripheral (subcutaneous) fat distribution, at any given BMI. This is a predisposition, not a fixed outcome — fat distribution responds to lifestyle, and the genetic signal represents a starting tendency rather than a ceiling or floor.

The reason central adiposity carries more metabolic consequence than the same amount of subcutaneous fat is anatomical and biochemical. Visceral fat depots drain into the portal vein, exposing the liver to elevated free fatty acids and inflammatory adipokines. This portal exposure drives hepatic insulin resistance, elevated triglycerides, and suppressed HDL — the lipid triad of metabolic syndrome. Subcutaneous fat, by contrast, releases its metabolic products into the systemic circulation where they are more dilute and buffered.

People with a genetic predisposition toward central fat distribution may find that waist circumference is a more sensitive personal health metric than total weight or BMI. Someone who has maintained stable weight may still accumulate central fat with age, stress, or sedentary periods — particularly if their genetic architecture favors visceral expansion. Monitoring waist circumference directly, rather than relying solely on BMI or scale weight, provides a more informative signal for this trait.

The physical activity interaction identified in the research (Graff et al. 2017) is directly relevant here. Regular exercise appears to preferentially reduce visceral fat relative to subcutaneous fat — a phenomenon observed across intervention studies. This preferential visceral reduction may be partly mediated by exercise-driven changes in adipose ECM remodeling, potentially involving ADAMTS family activity in visceral depots. Whether someone's specific genetic profile makes them more or less responsive to exercise-driven visceral fat reduction is an area of ongoing research.

Stress is a relevant modifier. Cortisol, the primary stress hormone, preferentially drives fat deposition in visceral depots. People with a genetic tendency toward central adiposity may find that periods of high stress have more pronounced effects on waist circumference than on total weight, because the stress-driven hormonal signal amplifies an existing genetic tendency.

Working with your body fat distribution result

The following steps are supported by evidence on central adiposity. Effect sizes vary between individuals and none of these is a guarantee, but each targets mechanisms relevant to the biological pathways this trait involves.

1. Combine resistance training with aerobic exercise. Both modalities reduce visceral fat, but together they are more effective than either alone. Resistance training preserves lean mass while aerobic exercise preferentially mobilizes visceral fat stores. Aim for a minimum of 150 minutes of moderate aerobic activity weekly alongside at least two resistance sessions.

2. Follow a Mediterranean-style dietary pattern. Mediterranean diets — high in olive oil, fiber, legumes, vegetables, and fish — have been associated with reductions in visceral fat and improvements in plasma BCAA levels. The fiber content improves insulin sensitivity through gut microbiome pathways, reducing the visceral fat accumulation driven by insulin resistance.

3. Reduce refined carbohydrates and added sugars. High-glycemic foods drive postprandial insulin spikes that preferentially direct fat storage toward visceral depots. Replacing refined carbohydrates with whole-food sources blunts this effect and reduces visceral fat accumulation over time.

4. Monitor protein and BCAA intake thoughtfully. Those with genetics that impair BCAA breakdown may benefit from avoiding excessive BCAA supplementation. Adequate dietary protein from whole food sources is appropriate; megadose BCAA supplements add BCAAs that the BCKDHB pathway may not efficiently clear.

5. Track waist circumference, not just weight. Waist circumference is a more informative metric for this trait than total weight or BMI. Measuring it monthly provides a direct signal of visceral fat trends.

6. Manage stress actively. Cortisol preferentially deposits fat in visceral compartments. Adequate sleep (7-9 hours) and deliberate recovery reduce chronic cortisol load and slow visceral fat accumulation that compounds genetic predisposition.

Related traits and genes

Body fat distribution shares biological territory with several other traits in your ExomeDNA profile. The ADAMTS family's ECM remodeling role overlaps with traits involving connective tissue and inflammation, while the BCAA-insulin resistance axis connects to metabolic traits more broadly.

• BMI and Obesity Genetic Risk — the complementary measure of total fat mass; a high reading on both traits suggests both quantity and central distribution are genetically influenced.
• Waist-to-Hip Ratio — a related fat distribution phenotype that captures similar visceral versus peripheral patterning through a different measurement approach.
• Triglyceride Levels — visceral fat is the primary driver of elevated circulating triglycerides; the two traits share metabolic pathway overlap.
• Type 2 Diabetes Risk — the BCKDHB BCAA-catabolism axis is directly linked to insulin resistance, connecting this trait's genetic architecture to T2D risk genetics.
• Fasting Insulin Levels — central adiposity and insulin resistance form a bidirectional feedback loop; your reading on this trait adds context for interpreting insulin-related results.

Frequently asked questions

Is body fat distribution different from BMI?

Yes, and the distinction matters. BMI measures the ratio of weight to height — a proxy for total fat mass. Body fat distribution measures WHERE fat is stored, specifically the proportion of fat in central versus peripheral depots. Someone with a normal BMI can carry a high proportion of visceral fat; someone with an elevated BMI may carry most fat subcutaneously. The waist circumference adjusted for BMI measure used in this GWAS deliberately separates the two signals, identifying genetic variants that affect distribution independently of total body fat. Central adiposity carries stronger metabolic associations than equivalent amounts of subcutaneous fat.

Does genetics fully determine where I store fat?

No. Genetics shapes predisposition, not outcome. The variants captured in this trait analysis represent tendencies in fat distribution that interact with lifestyle, hormones, age, and sex. Physical activity, dietary patterns, stress levels, and sleep quality all influence fat distribution meaningfully. A genetic predisposition toward central adiposity is a reason to pay attention to waist circumference and to prioritize the lifestyle factors that specifically reduce visceral fat — not a fixed sentence. The 2017 meta-analysis by Graff and colleagues specifically found that physical activity modifies how genetic variants express on fat distribution, which is a practically useful finding.

Why does visceral fat carry more health risk than subcutaneous fat?

Visceral fat — stored around the abdominal organs — drains directly into the portal vein, which delivers blood to the liver. This means the liver is exposed to elevated free fatty acids and inflammatory molecules released by visceral fat before those signals are diluted in the systemic circulation. The result is hepatic insulin resistance, elevated triglyceride production, and suppressed HDL. Subcutaneous fat releases the same molecules into the general circulation at much lower concentrations. The anatomical difference in drainage explains why two people with the same BMI can have very different metabolic risk profiles based on fat distribution.

What role do the ADAMTS genes play in fat storage?

ADAMTS proteins are enzymes that remodel the extracellular matrix — the structural scaffold surrounding cells in adipose tissue. Visceral and subcutaneous fat depots have different ECM architectures, and those differences partly determine how each depot expands as fat mass increases. ADAMTS3 and ADAMTS9 break down specific ECM proteins (collagen and versican/aggrecan, respectively) in ways that affect depot stiffness and expansion capacity. Variants in these genes that alter ECM remodeling rates may shift the balance of fat storage toward central depots. ADAMTSL3 and ACAN operate in related ECM pathways with overlapping functional implications for depot architecture.

Can I reduce visceral fat specifically?

Yes, and targeted approaches exist. Aerobic exercise preferentially reduces visceral fat relative to subcutaneous fat — an effect seen across controlled intervention studies. The Mediterranean dietary pattern has also shown specific reductions in visceral fat in randomized trials. Reducing refined carbohydrates and managing cortisol through sleep and stress management are additional evidence-supported strategies. Weight loss in general reduces visceral fat, but the lifestyle factors above reduce it preferentially, meaning they shift the distribution toward the less metabolically active subcutaneous pattern even without large changes in total weight.

How does BCKDHB connect to fat distribution?

BCKDHB encodes a key enzyme in the breakdown of branched-chain amino acids (leucine, isoleucine, valine). When this enzyme is less active, BCAAs accumulate in the blood. Elevated circulating BCAAs are one of the most reproducible metabolic signatures of insulin resistance — they appear before type 2 diabetes develops and correlate strongly with central adiposity. Visceral fat specifically has lower BCAA-catabolizing capacity than subcutaneous fat, meaning central adiposity and impaired BCAA clearance form a reinforcing relationship. Variants in BCKDHB that reduce enzyme efficiency may contribute to central fat accumulation through this insulin-resistance-adjacent pathway.

References

1. Graff M, Scott RA, Justice AE, et al. (2017). Genome-wide physical activity interactions in adiposity — A meta-analysis of 200,452 adults. PLOS Genetics. PMID: 28448500.

Wellness Information. ExomeDNA provides educational interpretation of genetic variants for general wellness purposes only. This is not a clinical finding, treatment recommendation, or clinical genetic test. Consult a healthcare provider before making medical decisions. See our methodology and test limitations for details.

This page is published by ExomeDNA. We interpret raw genetic data into educational genetic insights using polygenic scoring with ancestry calibration. Read our methodology for the full statistical approach.

Last reviewed: 2026-05-29.

ExomeDNA genetic results are for wellness and educational purposes only. Consult a clinician for personalized health guidance.